BioSight
Companies
MIMEDX GROUP, INC. logo

MDXG

NASDAQMARIETTA, GA
MIMEDX GROUP, INC.

MiMedx manufactures and sells human tissue-based products for surgical use across multiple specialties. The company operates in the regenerative medicine space, producing products derived from processed human tissue, and is focused on expanding its product offerings and market reach both domestically and internationally. MiMedx is a commercial-stage company generating revenue from its existing product portfolio while managing regulatory compliance, reimbursement negotiations with Medicare, and tissue procurement for manufacturing.

Price history not yet available for MDXG.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar